Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$4.28
+2.88%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+133.6%
Consensus $10.00 vs current $4.28
NASDAQ·Healthcare·Biotechnology
$4.28
+2.88%
Mkt Cap $55.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
+133.6%
Consensus $10.00 vs current $4.28